Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
484
-
Total 13F shares, excl. options
-
97.4M
-
Shares change
-
+3.45M
-
Total reported value, excl. options
-
$11.1B
-
Value change
-
+$391M
-
Put/Call ratio
-
1.18
-
Number of buys
-
224
-
Number of sells
-
-227
-
Price
-
$113.87
Significant Holders of RESMED INC - COM (RMD) as of Q4 2018
568 filings reported holding RMD - RESMED INC - COM as of Q4 2018.
RESMED INC - COM (RMD) has 484 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 97.4M shares
.
Largest 10 shareholders include Vanguard Group Inc (14.9M shares), BlackRock Inc. (11.8M shares), FMR LLC (7.64M shares), Capital World Investors (6.25M shares), STATE STREET CORP (6.09M shares), BAILLIE GIFFORD & CO (4.85M shares), WCM INVESTMENT MANAGEMENT, LLC (4.32M shares), GEODE CAPITAL MANAGEMENT, LLC (2.02M shares), NORTHERN TRUST CORP (1.68M shares), and JPMORGAN CHASE & CO (1.37M shares).
This table shows the top 484 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.